Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PULSE-SED: Local Anesthesia With Conscious Sedation vs General Anesthesia for Pulsed Field Ablation in Paroxysmal AF
NCT07877519Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of fentanyl, midazolam, Lidocaine Hydrochloride Injection, without epinephrine, methoxyphenamine hydrochloride, salbutamol and 4 more in Atrial fibrillation (AFib) (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Percentage of Participants With Recurrence of Atrial Tachyarrhythmia After the Blanking Period at 12 months. Started Jun 2026; status: recruiting.
02
Drugs
fentanylmidazolamLidocaine Hydrochloride Injection, without epinephrinemethoxyphenamine hydrochloridesalbutamol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07877519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07877519.